Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB25FMZBK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,351
Award facts
- Contract value 100% obligated
- $10,351.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded August 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of RYTARY ER (extended-release carbidopa-levodopa) 36.25 mg-145 mg capsules in quantities of 100 units. The contract carries a ceiling value of $10,351.48 and represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was competitively procured without set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical pharmaceutical products and medical commodities to support Department of Defense and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the DLA Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic areas. This particular delivery order for RYTARY, a neurological treatment used in Parkinson's disease management, reflects AmerisourceBergen's ongoing role in fulfilling federal medical procurement requirements through its comprehensive pharmaceutical prime vendor arrangement with the DLA.
Quick answers
Who was awarded contract SPE2DB25FMZBK?
SPE2DB25FMZBK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FMZBK worth?
The government has obligated $10,351 on SPE2DB25FMZBK.
Is contract SPE2DB25FMZBK an order under another contract?
Yes. SPE2DB25FMZBK is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZBK competed?
The extent of competition for SPE2DB25FMZBK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award